PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1778905-7	1991	The endopeptidase inhibitors phosphoramidon and thiorphan (5 x 10(-6) M) potentiated the action of VIP.	phosphoramidon	29-43	VIP peptides	Cavia porcellus	99-102	
1652635-3	1991	The tracheal relaxing activity of VIP was potentiated by enkephalinase inhibitors, thiorphan and phosphoramidon, while the activity of HDM was not potentiated.	phosphoramidon	97-111	VIP peptides	Cavia porcellus	34-37	
2196967-6	1990	The supersensitivity to VIP, following epithelium removal was abolished by phosphoramidon or thiorphan (NEP inhibitors), but unaffected by captopril (an ACE inhibitor).	phosphoramidon	75-89	VIP peptides	Cavia porcellus	24-27	
2695341-3	1989	Phosphoramidon potentiated responses to VIP in intact but not de-epithelialised preparations, and had no effect on i-NANC responses.	phosphoramidon	0-14	VIP peptides	Cavia porcellus	40-43	
8538872-6	1995	Phosphoramidon (5 x 10(-6) M) potentiated the relaxant responses of epithelium-intact GPT to both PACAP and VIP but did not affect the responses of epithelium-denuded GPT.	phosphoramidon	0-14	VIP peptides	Cavia porcellus	108-111	
2159651-6	1990	The neutral endopeptidase inhibitor phosphoramidon (5 x 10(-6) M) enhanced responses of NS to VIP but did not affect responses to NS in the absence of VIP.	phosphoramidon	36-50	VIP peptides	Cavia porcellus	94-97	
9533650-4	1998	Peptidase inhibition by captopril and phosphoramidon increased the relaxant effect and duration of action for original VIP but not for the VIP analog.	phosphoramidon	38-52	VIP peptides	Cavia porcellus	119-122